Provided by Tiger Trade Technology Pte. Ltd.

Biogen

182.31
-2.9800-1.61%
Pre-market: 182.830.5200+0.29%06:28 EDT
Volume:846.24K
Turnover:154.06M
Market Cap:26.75B
PE:20.74
High:184.32
Open:184.13
Low:180.48
Close:185.29
52wk High:202.41
52wk Low:110.04
Shares:146.70M
Float Shares:146.23M
Volume Ratio:0.92
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):8.79
EPS(LYR):8.79
ROE:7.39%
ROA:6.14%
PB:1.46
PE(LYR):20.74

Loading ...

Biogen advances salanersen into Phase 3 SMA trials with new Phase 1b data update

Reuters
·
Mar 05

Stoke Therapeutics, Biogen publish data from zorevunersen studies in NEJM

TIPRANKS
·
Mar 05

NEJM publishes first zorevunersen data showing disease-modifying potential in Dravet syndrome, Biogen says

Reuters
·
Mar 05

Biogen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 05

Biogen’s Uptal Patel to Join Fireside Chat at Leerink Global Healthcare Conference 2026

Reuters
·
Mar 04

Biogen Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Mar 03

Biogen Deepens Its ALS Footprint With Long-Term Qalsody Safety Registry

TIPRANKS
·
Mar 03

Biogen Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Feb 28

Biogen Faces Uncertain Outlook for Alzheimer's Drug But Pipeline Supports Growth, RBC Says

MT Newswires Live
·
Feb 27

Biogen (BIIB) Receives a Buy from RBC Capital

TIPRANKS
·
Feb 26

Biogen Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Feb 26

Organon posts FY 2025 Emgality sales of USD 174 million up 63%

Reuters
·
Feb 25

Biogen CEO Christopher Viehbacher to Join TD Cowen Annual Health Care Conference Fireside Chat

Reuters
·
Feb 24

Biogen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 24

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Feb 24

Biogen’s BIIB091 MS Trial Reaches Completion, Setting Up a Key Pipeline Catalyst

TIPRANKS
·
Feb 21

Biogen Initiated at Equal-Weight by Barclays

Dow Jones
·
Feb 20

Biogen Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Feb 20

Biogen (BIIB) Valuation Check After Earnings Momentum And Analyst Optimism

Simply Wall St.
·
Feb 19

Nicole Murphy, Head of Pharm Ops and Tech, acquires Biogen Inc. common shares

Reuters
·
Feb 18